# Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers

> **NCT02210247** · PHASE1 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 60 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** EXPAREL

## Key facts

- **NCT ID:** NCT02210247
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02210247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02210247, "Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02210247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*